Skip to content
2000
Volume 19, Issue 7
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

The current standard method for type 1 diabetes (T1D) management majorly focuses on controlling blood glucose levels with exogeneous insulin administration. Recent developments have focused on finding ways to predict and prevent the development of T1D, as well as finding a curative therapy for T1D. Such developments include β-cell replacement therapy by islet transplantation, non-insulin adjunct therapy, gene and stem cell-based therapies, immunotherapy, and automated treatment with an artificial pancreas. In recent years, non-traditional alternative therapy has also become a popular treatment option for T1D. This review discusses the various therapeutic options for T1D currently under various stages of development, the challenges associated with the present strategies, and their potential to eventually change the way T1D is treated.

Loading

Article metrics loading...

/content/journals/cdr/10.2174/1573399819666221202161259
2023-09-01
2025-05-05
Loading full text...

Full text loading...

/content/journals/cdr/10.2174/1573399819666221202161259
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test